XML 19 R7.htm IDEA: XBRL DOCUMENT v3.23.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
10 Months Ended 12 Months Ended
Dec. 31, 2021
Dec. 31, 2022
Cash flows from Operating Activities:    
Net (loss) income $ 10,815,018 $ (4,742,618)
Adjustments to reconcile net (loss) income to net cash used in operating activities:    
Formation costs paid by sponsor in exchange for issuance of Class B ordinary shares 6,894  
Offering expenses related to warrant issuance 1,984,130  
Excess value of Private Placement Warrants 1,066,666  
Interest earned on marketable securities held in Trust Account (7,819) (3,753,097)
Decrease in fair value of warrants (14,982,447) (1,477,374)
Stock compensation expense   224,250
Change in fair value of conversion option   (7,200)
Amortization of discount on convertible promissory note   8,000
Changes in operating assets and liabilities:    
Other receivable   (53,200)
Prepaid expenses (527,259) 325,984
Accrued expenses and accounts payable   (145,362)
Accrued offering costs and expenses 604,474  
Deferred liabilities   6,721,861
Net cash used in operating activities (1,040,343) (2,898,756)
Cash Flows from Investing Activities:    
Investment held in Trust Account (265,147,800)  
Net cash used in investing activities (265,147,800)  
Cash flows from Financing Activities:    
Proceeds from convertible promissory note - related party   1,200,000
Proceeds from promissory note - related party   786,096
Proceeds from Initial Public Offering, net of underwriters' fees 259,844,844  
Proceeds from private placement 8,302,958  
Advances from related parties 150,000  
Payments to related parties (150,000)  
Payments of offering costs (1,004,685)  
Net cash provided by financing activities 267,143,117 1,986,096
Net change in cash 954,974 (912,660)
Cash, beginning of the period   954,974
Cash, end of the period 954,974 42,314
Supplemental disclosure of noncash investing and financing activities:    
Remeasurement of Class A ordinary shares subject to possible redemption 38,782,274 3,760,916
Deferred financing costs included in accrued expenses   728,745
Deferred underwriting commissions charged to additional paid in capital 9,280,173  
Fair value of capital contribution by Sponsor to Anchor Investors 11,107,653  
Forfeiture of 558,805 founder shares 56  
Deferred offering costs paid by Sponsor in exchange for issuance of Class B ordinary shares 18,104  
Initial classification of warrant liability $ 23,422,455  
Private warrants issued upon conversion of related party promissory note   480,000
Capital contributed upon settlement of related party note   $ 720,800